Treatment of Dyslipidemia in Common Liver Diseases
- PMID: 29684459
- PMCID: PMC6558967
- DOI: 10.1016/j.cgh.2018.04.023
Treatment of Dyslipidemia in Common Liver Diseases
Conflict of interest statement
Conflicts of interest
The authors disclose no conflicts.
References
-
- Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63:2889–2934. - PubMed
-
- Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003;98:960–967. - PubMed
-
- Zimmermann H Drug-induced liver disease In: Hepatotoxicity, the adverse effects of drugs and other chemicals on the liver. 1st ed New York: Appleton-Century-Crofts, 1978:351–353.
-
- Zimmermann H Drug-induced liver disease In: The adverse effects of drugs and other chemicals on the liver. 2nd ed Philadelphia: Lippincott Williams & Wilkins, 1999:428–433.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical